NOACs Not Advised for Frail Elderly With AFib
|
|
The use of non–vitamin K antagonist oral anticoagulants (NOACs) has been rapidly increasing to manage atrial fibrillation (AFib) and related stroke risk, but a recent study is a reminder that the agents are not for everyone. Find out why Dutch researchers advise against switching from vitamin K antagonists to NOACs in frail patients with AFib.
|